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Figure 2 Cytotoxicity of the ethanol extracts of eggplant calyx against four different cell lines. Closed circles, HRA (human 
ovarian cancer); open circles, HEK293 (human embryonickidney); closed triangles, HLE, (human hepatoma); open triangles, 
HeLa (human cervical cancer), KB (open square). Data are expressed as mean ± S.E. (n = 6), and **P < 0.01, ***P < 0.001 vs 

















































Figure 3 Eggplants used in the present investigation.  
Eggplants (Senryo-nasu, A) were cut into the calyx parts (B)  




Figure 4   Cytotoxicity of the ethanol extracts prepared from the calyx parts (closed circles) and from the edible parts (open 
circles) of eggplants. Data are expressed as mean ± S.E. (n = 6) , and **P < 0.01, ***P < 0.001 vs control (0 mg/ml) group 



















?? IC50 ? 41 μg/m1?????Figure 5?? 
 
 
Figure 5  Activity-guided fractionation of eggplant calyx. IC50, concentration of the fraction required for 50% inhibition of 




???????????????????????????Fr. 1?Fr. 2?Fr. 3?Fr. 4??
?????????????????Fr. 2?0.68 g????????????IC50, 30 μg/ml??
Fr. 2??????????????????ODS?????????????????
????????Fr. 2-1?Fr. 2-2?Fr. 2-3????Figure 6??????HRA??????
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?????????????Fr. 2-2???????????????IC50, 8.0 μg/ml???
?? Fr. 2-2 ??????HPLC?????compound 1 (< 0.5 mg)?compound 2 (< 0.5 mg)?
compound 3 (9.1 mg)?compound 4 (2.2 mg)????Figure 6??Compound 1?2?????
???????????????????????Compound 3?4?HRA??????





Figure 6  Activity-guided fractionation of the ethyl acetate fraction of eggplant calyx extract. (A) Cascade of the fractionation. 
IC50, concentration of the fraction required for 50% inhibition of proliferation of HRA cells. (B) RP-HPLC chromatograms of 
Fr. 2-2. Column :C18-AR-?(10?150 mm), solvent:A (H2O) - B (CH3CN), 0 – 100 (0 - 30 min), flow speed:3 ml/min; wave 







3.1  Compound 3 ????? 
 
? Compound 3 ???? 1H-??? 13C-NMR ? EI-MS ??????NMR ??????
Table 1???? 
? Compound 3? 13C-NMR?????????? 1????????? 10??????
? 4 ?????????????1H-NMR ????????????????????
?δH 6.16 ppm, 1H, d, 15.0 Hz?δH 7.48 ppm, 1H, dd, 15.0 Hz / δH 6.11 ppm, 1H, dd, 10.7 Hz?δH 




? ?? 13C-NMR?????????????? HMBC??????δH 2.34 ppm / δC 176.5 
ppm???δH 2.54 ppm / δC 200.1 ppm???????????????????????
????????????????????? δC 20 ~ 30 ppm?????? δH 1.2 ~ 1.6 
ppm?16H????????????????compound 3?????????????
??????? 
? ??? EI-MS????????[M+H+] m/z = 294????????????????
?? m/z = 276, 223, 171, 166, 155, 95??????????????????? HI-MS?
?????compound 3????? C18H30O3???????????????compound 3
??9-oxo-(10E,12Z)-octadecadienoic acid (9-E,Z-KODE)?????????Figure 7?? 
 
 
Figure 7  Chemical structure of 9-oxo-(10E, 12Z)-octadecadienoic acid (9-E,Z-KODE)  







Table 1. 1H- and 13C-NMR spectral data of compound 3. 
Proton number 1H-NMR data (ppm) 13C-NMR data (ppm) 
1 ? 176.5 
2 2.34 (t, J = 7.7Hz) 33.5 
3 1.62 (m) 24.6 
4?7 1.2 - 1.4 (m) 29.0 - 31.5 
8 2.54 (t, J = 7.5 Hz) 41.0 
9 ? 200.1 
10 6.16 (d, J = 15.0 Hz) 129.4 
11 7.48 (dd, J = 15.0, 11.4 Hz) 137 
12 6.11 (dd, J = 11.4, 10.7 Hz) 126.9 
13 5.90 (dt, J = 10.7, 8.1 Hz) 143.0 
14 2.30 (dt, J = 7.8 Hz) 28.5 
15 1.63 (m) 24.6 
16 1.2-1.4 (m) 29.0 
17 1.3 (m) 22.5 
18 0.89 (t, J = 6.9 Hz) 14.0 
 
 
3.2? Compound 4 ????? 
 
? Compound 4? 1H-?13C-NMR??? EI-MS??????NMR ?????? Table 2
???? 
? Compound 4? 13C-NMR?????????? 1????????? 10??????
? 4?????????????1H-NMR??????????????????δH 6.07?





? ??? compound 4? EI-MS?????????[M+H+] m/z = 294?????????
??m/z = 223, 171, 166, 151, 95???????????????????HI-MS???
?????compound 4??????C18H30O3???????????????compound 





? ?  Table 2  1H- and 13C-NMR spectral data of compound 4. 
Proton number 1H-NMR data (ppm) 13C-NMR data (ppm) 
1 – 177.6 
2 2.36 (t, J = 7.3 Hz) 33.6 
3?7 1.2 - 1.6 (m) 22.5 - 32.7 
8 2.53 (t, J = 7.3 Hz) 40.4 
9 – 201.0 
10 6.07 (d, J = 15.4 Hz) 127.9 
11 7.12 (dd, J = 15.4, 9.8 Hz) 143.0 
12 6.15 (m) 128.8 
13 6.18 (m) 145.7 
14 2.17 (m) 33.1 
15~17 1.2-1.6 (m) 22.5 - 32.7 




Figure 8  9-oxo-(10E, 12E)-octadecadienoic acid (9-E,Z-KODE)  



























???? 9-EE-KODE ???????????????? HRA???? IC50? 6.5 μM









Table 3  Cytotoxicity of 9-EE-KODE against various cancer cells. 
Cell line Origin 
IC50 (μM) 
9-EE-KODE Adriamycin 
HRA Human ovarian cancer 6.5 ± 1 0.15 ± 0.01 
MIA PaCa-2 Human pancreatic cancer 32 ± 3 1.4 ± 0.1 
HT-1080 Human fibrosarcoma 43 ± 2 0.72 ± 0.27 
KB Human cervical carcinoma 54 ± 19 0.18 ± 0.00 
ACC-MESO-1 Human malignant mesothelioma 59 ± 8 0.76 ± 0.08 
MCF-7 Human breast cancer 74 ± 23 0.57 ± 0.17 
P388 Mouse leukemia 48 ± 6 0.18 ± 0.00 
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Figure 9 The contents of 9-oxo-(10E, 12E)-octadecadienoic acid (9-EE-KODE) in the eggplants of various cultivars. Data are 











Figure 10  The contents of 9-E,E-KODE in the various parts of eggplants (Naga-nasu).  




















































Fugure 12   Signal pathways to cause apoptosis 
16 
 
1.? Compound 4 (9-EE-KODE) ????????? 
 
? ???????? 9-EE-KODE ????????????????????????
?????????????????????????  
 









?0.046 g?? Jones????????? 30 min ??????????????????
??NaCl?????????????????????????????0.037 g???
??? 9-EE-KODE ? MeOH/??4?1???????? ODS ???????????
?????0.029 g ??????? HPLC??? NMR??????Figure 13?? 
 






      B 
Proton number 
?? 9-EE-KODE  
1H-NMR data (ppm) 
???? 9-EE-KODE 
1H-NMR data (ppm) 
1 – – 
2 2.35 (t, J = 7.3 Hz) 2.36 (t, J = 7.3 Hz) 
3?7 1.2 - 1.4 (m) 1.2 - 1.6 (m) 
8 2.53 (t, J = 7.4 Hz) 2.53 (t, J = 7.3 Hz) 
9 – – 
10 6.07 (d, J = 15.4 Hz) 6.07 (d, J = 15.4 Hz) 
11 7.11 (dd, J = 15.5Hz) 7.12 (dd, J = 15.4, 9.8 Hz) 
12 6.15 (m) 6.15 (m) 
13 6.19 (m) 6.18 (m) 
14 2.15 (m) 2.17 (m) 
15~17 1.2-1.4 (m) 1.2-1.6 (m) 
18 0.89 (t, J = 7.0 Hz) 0.89 (t, J = 7.0 Hz) 
 
        C 
 
 
Figure 13  (A) Scheme of the synthesis of 9-EE-KODE. (B) Comparison of synthesized and isolated 9-EE-KODE by 
1H-NMR (ppm). Solvent, CDCl3. (C) Chromatograms of synthesized 9-EE-KODE. Column: Cosmosil 5C18-AR-II (10 × 150 



























? HRA??? 9-EE-KODE ?????????24??????? MTT ??? BrdU ?
????????????DNA???????????????? 9-EE-KODE ???
????????????????????????????? IC50 ??9.2 μg/ml (31 





Figure 14  Cytotoxic effect of 9-EE-KODE on HRA cells evaluated by MTT (A) or BrdU assays (B) 
HRA cells were treated with 9-EE-KODE for 24 h, and the cell viability was evaluated. Data were expressed 
as mean ± S.E. (n = 3 for MTT, and n = 6 for BrdU tests). **P < 0.01, ***P < 0.001 vs control (0 μg/ml) 

















































??? 1 μg/ml????? DNA?????????????????????????
????????????????????Figure 15A?? 







Figure 15   Effect of 9-EE-KODE on DNA fragmentation in HRA cells.  
(A) HRA cells were treated with 9-EE-KODE for 24 h, and DNA in the cells was separated by 
electrophoresis. (B) HRA cells were treated with 9-EE-KODE for 4 h, and the amount of DNA-histone 
complex was evaluated. Data were expressed as mean ± S.E. (n = 3). *P < 0.05 vs control (0 μg/ml) 
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Figure 16  Effect of 9-EE-KODE on phosphatidylserine cell in the outer membrane of HRA cells.  
HRA cells were treated with 9-EE-KODE for 12 h, and phosphatidylserine in outer membrane was 
detected by Annexin V staining. (A) Representative microscopic photographs. Bar in a photo represents 
0.02 mm. (B) Positively stained cells were counted in 4 – 6 different microscopic fields of view of a 
single culture well, and data were exhibited as mean ± S.E. *P < 0.05, **P < 0.01, ***P < 0.001 vs 
















  ???? 9-EE-KODE ? HRA ????????? 24 ????????? caspase-3?
?7??????????????????????9-EE-KODE? HRA??? caspase-3?




   
Figure 17  Effect of 9-EE-KODE on the activity of caspase-3/7 in HRA cells.  
HRA cells were treated with 9-EE-KODE for 24 h, and the activities of caspase-3/7 
were measured. Data were exhibited as mean ± S.E (n = 3). **P < 0.01, ***P < 0.001 
vs control (0 μg/ml) group evaluated by Bonferroni/Dunnett’s multiple t-test. 
 
 














































9-EE-KODE ????? 3???? JC-10????????????????????
???????????????? HRA???????9-EE-KODE????????




Figure 18   Effect of 9-EE-KODE on mitochondrial membrane potential in HRA cells. 
HRA cells were treated with 9-EE-KODE for 3 h, and the mitochondrial membrane potential was evaluated by 
JC-10 staining. Data were exhibited as mean ± S.E. (n = 6). *P < 0.05 control (0 μg/ml) group evaluated by 
Bonferroni/Dunnett’s multiple t-test. 
 
 
7.?  9-EE-KODE?HRA????????????cytochrome c?????
?? 
  
? ??????????cytochrome c ??Apaf-1?apoptic protease activating factor 1??
????Apaf-1?????????caspase????????????????????
????????????????????cytochrome c?Apaf-1??? caspase-9 ??
???????caspase-9 ???????????????????? caspase-9 ???
?????????????????caspase-3 ?????? caspase ????????
??????????? 





? ?????9-EE-KODE ????? HRA ???????????????????
cytochrome c????????????? cytochrome c???????????????
??????9-EE-KODE???????cytochrome c???????????????
??????????????????Figure 19?? 
                 A 
 
                 B 
 
Figure 19  Effect of 9-EE-KODE on cytochrome c localization in mitochondrial and cytosol fractions in 
HRA cells. 
HRA cells were treated with 9-EE-KODE for 24 h, and the cell lysate was separated into mitochondrial and 
cytosolic fractions. The content of cytochrome c was evaluated by western blot analysis. (A) Representative 
photographs of the membrane. (B) Area of the band was measured by image analyzer, and data were 
exhibited as mean ± S.E. (n = 3). **P < 0.01, ***P < 0.001 vs each control (0 μg/ml) group evaluated by 
Bonferroni/Dunnett’s multiple t-test. 
24 
 






??? Bad?Bid?Bax?Bim ???????????death ????????????
????????????? cytochrome c ?????????Bad ?????????
?????Bcl-xL????????????????????????Bad ?????
???????????????????????????????????? Bid ? 
Fas ?????????????? caspase-8 ???????????????????
??tBid????????????????Bax ? Bim ??????????? death 
?????????????????????DNA ?????? caspase??????
???p53 ? Bax? Noxa???????????????????????????
? cytochrome c ????????????????????????Bcl-xL?Bcl-2?Bax 
???????????????VDAC??????????? cytochrome c ????
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Figure 21  Effect of 9-EE-KODE on the expression levels of Bcl-2 subfamily proteins in HRA cells. 
HRA cells were treated with 9-EE-KODE for 0, 6, 12 and 24 h, and the proteins levels of Bcl-2, Bcl-xL and Bax 
were evaluated by western blot analysis. (A) Representative photographs of the membrane. (B – D) Area of each 
band was measured by an image analyzer and the data were exhibited as mean ± S.E. (n = 3). *P < 0.05, **P < 0.01 





Figure 22  Effect of 9-EE-KODE on the expression levels of Bcl-2 subfamily proteins in HRA cells. 
HRA cells were treated with 9-EE-KODE for 24 h, and the proteins levels of Bcl-2, Bcl-xL and Bax were evaluated 
by western blot analysis. (A) Representative photographs of the membrane. (B – D) Area of each band was measured 
by an image analyzer and the data were exhibited as mean ± S.E. (n = 3). *P < 0.05, **P < 0.01 vs each control (0 
















9-oxo-(10E, 12Z)-octadecadienoic acid (9-EZ-KODE)??? 9-oxo-(10E, 12E)-octadecadienoic 











??????????? linoleic acid ??????????????????????
????????????? 
? 9-EE-KODE ??? 9-EZ-KODE ??????????????? 0.03%??? 0.12%
????????? HRA?????? IC50? 1.9??? 9.7 μg/ml?????????
???????????? IC50??0.5 mg/ml???????????????????




































? KB (Human cervical carcinoma)?ACC-MESO-1 (Human malignant mesothelioma)?MCF-7 
(Human breast cancer)?Mia-PaCa-2 (Human pancreatic cancer)?HT-1080 (Human fibrosarcoma)
??????????????????? ?? ?? ????? HRA (Human ovarian 
cancer) ?????????????????????? ?? ?? ????????
?????????????????? 10%?????????FBS?Sigma Aldrich?
St. Louis?MO?USA????????100 unit/ml????????????100 mg/ml???
??????????????? RPMI 1640??????????5% CO2? 37???
???? 





? ????? 96??????????????????? 5 × 10? cell / 198 μl / well ?
?????24 h?????????DMSO? 10 mg/ml?1 mg/ml?100 μg/ml?10 μg/ml
?????????? 2 μl???????????100?10?1?0.1 μg/ml????? 72 h
????????????? DMSO????????????? adriamycin??????
?????????????????????MTT??????? 3 mg/ml???? 20 
μl????????? 4 h????????????DMSO 170 μl?????????
formazan?????570 nm??????ARVO MX 1420 multilabel counter (Perkin Elmer?






? ???????????????????????????????????? 14 kg
??????? 2.8 kg?????????????????????????????
2.6 x 102 g???????????? 2 l??????????? 3?????????
???????????????????? 7.6 g??????? 80?????? 3.6 l
????????? 1.2 l? 3??????????????????????? 80%?
30 
 
???????? 3.6 l?????????? 1.2 l? 3????????????? 1.2 l
? 3 ?????????????????????????????????????
??0.8 g??????????1.3 g??????5.2 g?????? 
? ???????????????? 200 g??????? 2 l???????????
?? 12.5 g???? 
? ??????????????????????????????10 mg/ml????
?? DMSO?????–20??????? 
? ??????? 1.3 g????????????????????????? 60N??
???????4 cm × 20 cm????????????????????2 : 8 : 0.1?[13]
????????????????????????????Fr. 1?Fr. 4??????
?? 7.2 mg?683 mg?142 mg?258 mg??Fr. 2?683mg?? ODS??????????
?????????? 140C18-OPN??????4 cm × 20 cm????????????
?1:1?4:1?1:0?300 ml?????????????Fr. 2-1?2-3????? 225.1 g?48 mg?
176 mg?????Fr. 2-2?48 mg???? HPLC?????? C18-AR-?column 10 × 150 mm?
??????????? 3 ml/min???????????50:50?0 min?30:70?30 min?
0?100?32 min???????280 nm? UV?????Compound 1?19 min?0.13 mg??
2?20 min?0.25 mg??3?24 min?9.1 mg??4?26min?2.2 mg?????Compound 3?
4???????NMR?Bruker ABANCE 600?MA?USA?? EI-MS????????)
?????? 
? Compound 3? 4????????????????????? HPLC???????
????????? 5C18-AR-?column 4.6 × 150 mm?????????????????
????50:50?0 min?30:70?20 min?0?100?22 min?????1 ml/min???? UV 280 
















? ???????????????????????  
 
?MTT????9-EE-KODE??????????? 
? 9-EE-KODE????24 h??MTT??????????????????????? 
 
?BrdU????9-EE-KODE??????????? 
? 5-Bromo-2'-deoxyuridine Labeling & Detection Kit ??Roche Applied,Science?Mannheim? 
Germany???????MTT?????????MTT???????10 μl?BrdU???
??????37?? 2 h ??????????????????DNA????????
????????????200 μl/well ? FixDenat ?????30 min?25°C?????
??????????????100 μl/well ?POD???BrdU ???????????




? ???????50 ml???????????????2 × 106 ??HRA???????
24 h ???????DMSO?Control????9-EE-KODE?1?5?10?100 μg/ml ???
?????????24 h????????????????????100 mM Tris-HCl?
pH 8.5?5 mM EDTA?0.2 M NaCl?0.2% SDS?0.2 mg/ml proteinase K??330 μl???37?
???????????????????????????????1.5 x 104 rpm?10 min?
?????5 M NaCl 141 μl??????????????????????1.5 x 104 rpm?
20 min??????????????????????470 μl????????????
???????1.5 x 104 rpm?20 min??????????????70%????? 400 μl
????????????????????1.5 x 104 rpm?20 min???????????
?????15 μl????????RNase A (10 mg/mL in Tris-EDTA buffer) ?1 μl????
37????????????????????????3 x 103 rpm?20 min??????





? Cell death detection ELISAPLUS?Roche Applied Science?Penzberg?Upper Bavaria?Germany?








?????? V ??? 
? ???????50 ml?? HRA??? 1.5 × 104 cells/well? HRA???????6 h?
????????? 9-EE-KODE ??????24 h????PBS??????????
??? V-????????Medical & Biological Laboratories?????? 10 μl?????
????? 15 min???????????PBS ???????????????? 
 
?Caspase-3/-7???? 
? 96?????? HRA??? 2 × 104 cells/well????24 h????9-EE-KODE??
??? 24 h??????????????Caspase-3/7 reagent?Promega?Madison?WI?
USA?? 100 μl??????? 1 h?????????? 498 nm????? 521 nm??
??????????Perkin Elmer?Winter Street Waltham?MA?USA??????? 
 
??????????????? 
? 96????????HRA???1.5 × 104 cells/well????24 h????9-EE-KODE ?




????????? Bcl-2 ???????????????? 
? 6??????HRA???1.5 × 104 cells/well????9-EE-KODE??????24 h??
?????????????????????????2 x 103 rpm?20 min??????
lysis buffer?50 M Tris-HCl, pH8.0?0.15 M NaCl?0.5% sodium deoxycholate?0.1% SDS, 1.0 % 
NP-40 substitute??100 μl?????????????????????????BCA ?
????????????Thermo Scientific?Rockford?IL?USA???????25 μg?
??????12%??????????????SDS-PAGE?????????????
???Precision Plus ProteinTM Standards Dual Color?Bio-Rad? ????????????
???????????????????ATTO AE-6687 HorizBLOT 2M?ATTO????
?????ImmobilonTM-P Transfer Membrane?Millipore?Billerica?MA?USA?????






????IgG?1:1 x 104?Jackson Immuno Research?Reston?VA?USA????????1 






??????????????? Cytochrome  c???? 
? 6?????? HRA??? 1.5 × 104  cells/well???? 24 h????9-EE-KODE?





??? ???? ???? kDa 
Bcl-2 Cell Signaling?Danvers?MA?USA? 1:1000 26 
Bcl-xL Cell Signaling 1:1000 30 
Bax Cell Signaling 1:1000 20 
Cytochrome c Abcam 1:500 12 
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